RadNet's latest collaboration aims to create an AI-powered SmartTechnology to improve patient experience and operational efficiency in ultrasound.

RadNet's latest collaboration aims to create an AI control system for image interpretation to ensure AI scalability, performance monitoring and safety.

RadNet (NASDAQ:RDNT – Free Report) had its target price hoisted by Truist Financial from $80.00 to $94.00 in a research note ...

Truist Financial analyst David S Macdonald reiterated a Buy rating on Radnet (RDNT – Research Report) today and set a price target of $94.00. The company’s shares closed last Wednesday at $82.49.

Mutual of America Capital Management LLC cut its position in shares of RadNet, Inc. (NASDAQ:RDNT – Free Report) by 10.4% ...

Below is Validea's guru fundamental report for RADNET INC (RDNT). Of the 22 guru strategies we follow, RDNT rates highest using our Quantitative Momentum Investor model based on the published ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $83.25, ...

DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control ...

DeepHealth, a wholly-owned subsidiary of RadNet (RDNT), has received expanded FDA 510(k) clearance for its innovative mammography software.

DeepHealth's AI-powered informatics portfolio features the newly introduced Diagnostic Suite™ and TechLive™1, integrated ...